CINCINNATI--(BUSINESS WIRE)--June 20, 2005--(NASDAQ:VIVO) -
FORTUNE Small Business announced today that Meridian Bioscience, Inc.,
has been ranked 80 on the fifth annual FSB 100 list of the 100 fastest
growing small companies in America. The list, which is comprised of
public companies, appears in the July/August issue of FORTUNE Small
Business, available on newsstands July 4 and at www.fsb.com.
John A. Kraeutler, President and Chief Operating Officer, stated,
"This recognition by FORTUNE Small Business is a strong endorsement of
Meridian's commitment to improve healthcare through superior tests for
faster diagnosis of disease and life science technologies for the
development and manufacturer of diagnostics and biopharmaceuticals."
To compile the list, FORTUNE Small Business asked financial
research firm Zacks to screen annual reports for public companies with
annual revenue of less than $200 million and a stock price of more
than $1. Within that group, companies were ranked based on the past
three years' earnings growth, revenue growth, and stock performance.
Real estate firms and banks, which had begun to override the list in
recent years, were not considered for the list this year.
Meridian is a fully integrated life science company that
manufactures, markets and distributes a broad range of innovative
diagnostic test kits, purified reagents and related products and
offers biopharmaceutical enabling technologies. Utilizing a variety of
methods, these products provide accuracy, simplicity and speed in the
early diagnosis and treatment of common medical conditions, such as
gastrointestinal, viral, and respiratory infections. Meridian
diagnostic products are used outside of the human body and require
little or no special equipment. The Company's products are designed to
enhance patient well-being while reducing the total outcome costs of
healthcare. Meridian has strong market positions in the areas of
gastrointestinal and upper respiratory infections, serology,
parasitology and fungal disease diagnosis. In addition, Meridian is a
supplier of rare reagents and specialty biologicals along with
proteins and other biologicals used by biopharmaceutical companies
engaged in research for new drugs and vaccines. The Company markets
its products to hospitals, reference laboratories, research centers,
veterinary testing centers, physician offices and diagnostics
manufacturers in more than 60 countries around the world. The
Company's shares are traded through Nasdaq's National Market, symbol
VIVO. Meridian's website address is www.meridianbioscience.com.
CONTACT: Meridian Bioscience, Inc.
John A. Kraeutler, 513-271-3700
SOURCE: Meridian Bioscience, Inc.